Pregled bibliografske jedinice broj: 1221480
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation // Thrombosis and haemostasis, 122 (2022), 9; 1542-1548 doi:10.1055/a-1753-2748 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1221480 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
DOAC Dipstick Testing Can Reliably Exclude the
Presence of
Clinically Relevant DOAC Concentrations in
Circulation
Autori
Margetić, Sandra ; Ćelap, Ivana ; Huzjan- Lovrenčić, Arijana ; Bosnar Puretić, Marijana ; Šupraha Goreta, Sandra ; Čajević Glojarić, Anesa ; Delić Brkljačić, Diana ; Mioč, Pavao ; Harenberg, Job ; Hetjens, Svetlana ; Weiss Christel
Izvornik
Thrombosis and haemostasis (0340-6245) 122
(2022), 9;
1542-1548
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
oral anticoagulants ; DOAC Dipstick ; urine samples
Sažetak
In certain clinical situations, it is necessary to determine whether clinically relevant plasma levels of direct oral anticoagulants (DOACs) are present. We examined whether qualitative testing of DOACs in urine samples can exclude DOAC plasma concentrations of ≥30 ng/mL. This prospective single-center cohort study included consecutive patients treated with an oral direct factor Xa inhibitor (DXI) (apixaban, n = 31, rivaroxaban, n = 53) and direct thrombin inhibitor (DTI) (dabigatran, n = 44). We aimed to define the negative predictive value (NPV) and other statistical parameters of detecting DXIs and DTIs by DOAC Dipstick at plasma concentrations of ≥30 ng/mL. We also determined the best-fit threshold plasma levels using chromogenic substrate assays by logistic regression analysis. Between July 2020 and July 2021, 128 eligible patients (mean age 66 years, 55 females) were included into the study. The NPVs and sensitivities for DXI and DTI of DOAC Dipstick were 100% at ≥30 ng/mL plasma, for specificities 6 and 21% and for positive predictive values 62 and 72%, respectively. All diagnostic statistical tests improved to values between 86 and 100% at best-fitting plasma thresholds of ≥14 ng/mL for DXI and ≥19 ng/mL for DTI. Visual analysis using the DOAC Dipstick was 100% in agreement with that of the optoelectronic DOASENSE Reader for all the three DOACs. DOAC Dipstick testing can reliably exclude the presence of DOACs in urine samples at best-fitting thresholds of >14 and >19 ng/mL in plasma. The performance of the DOAC Dipstick at detecting lower DOAC concentrations in plasma requires confirmation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
IP-2016-06-8208 - Novi oralni antikoagulansi: povezanost koncentracije lijeka i antikoagulantnog učinka (LAB-NOAC) (Margetić, Sandra, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Sandra Šupraha Goreta
(autor)
Arijana Lovrenčić-Huzjan
(autor)
Ivana Ćelap
(autor)
Sandra Margetić
(autor)
Diana Delić-Brkljačić
(autor)
Marijana Bosnar-Puretić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE